Completed OBSERVATIONAL NCT05183087

Long-Term Effects of Repetitive, Low-Level Blast Exposure on Special Operations Forces Service Members (ReBlast)

Pilot Study of Long-Term Effects of Repetitive, Low-Level Blast Exposure (RLLBE) on Special Operations Forces (SOF) Service Members

Sponsor: Massachusetts General Hospital

Conditions Blast Injuries Traumatic Brain Injury

Interventions 3T Connectome MRI 7 Tesla MRI Blood Biomarkers Cognitive and Behavioral Assessments TSPO PET Tau PET

Updated 4 times since 2022 Last updated: Apr 3, 2023 Started: Jul 1, 2021 Primary completion: Feb 28, 2023 Completion: Feb 28, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05183087, this observational or N/A phase trial focuses on Blast Injuries and Traumatic Brain Injury and remains completed. Sponsored by Massachusetts General Hospital, it has been updated 4 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
May 2023 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Feb 2022 — May 2023 [monthly]

Recruiting

First recorded

Jul 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Massachusetts General Hospital

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States